Epidermolysis bullosa – Life with Disease

Go back

Epidermolysis bullosa is a group of rare genetic conditions that make the skin extraordinarily fragile, tearing and blistering from even the gentlest touch or friction. The condition is present from birth or early childhood and affects every aspect of daily life, from wearing clothes to eating meals, turning routine activities into challenges that require careful attention and constant care.

Understanding the Prognosis

The outlook for someone living with epidermolysis bullosa depends greatly on which type and subtype they have. This condition exists on a wide spectrum, ranging from relatively mild forms that people can manage throughout a normal lifespan, to severe forms that present life-threatening complications early in life.[1]

For individuals with mild cases of EB simplex (the most common type), the prognosis is generally favorable. These individuals may experience blistering primarily on their hands and feet, especially in areas of friction or pressure, but the condition rarely threatens overall health or significantly shortens life expectancy. Many people with milder forms go on to live full, productive lives, though they must remain vigilant about protecting their skin.[2]

The more severe forms of epidermolysis bullosa, particularly certain subtypes of junctional EB and dystrophic EB, carry a much more serious prognosis. In the most severe cases, complications can be fatal during infancy or early childhood. Causes of early death may include severe infection spreading through the bloodstream (a condition called sepsis), breathing problems from blocked airways due to blistering, or severe malnutrition and dehydration when blisters affect the mouth and digestive system.[2]

For those who survive into adulthood with severe dystrophic EB, life expectancy may range from infancy to approximately 30 years of age. One of the most significant long-term concerns is the dramatically increased risk of developing squamous cell carcinoma, an aggressive type of skin cancer. This cancer is the leading cause of death in people with severe forms of dystrophic EB. The constant cycle of wounding and healing creates an environment where abnormal cells can develop, and these cancers tend to be more aggressive and harder to treat than typical skin cancers.[2][4]

⚠️ Important
Statistics and survival estimates provide general guidance, but every person’s experience with epidermolysis bullosa is unique. Even within the same type and subtype, severity can vary dramatically between individuals. Some people defy expectations and live longer, healthier lives than predicted, while others face unexpected complications. Regular monitoring by a specialized medical team offers the best chance for managing complications early and maximizing quality of life.

Natural Progression Without Treatment

If epidermolysis bullosa goes untreated or is inadequately managed, the disease follows a course marked by progressive complications that compound over time. The fundamental problem—skin that cannot withstand normal friction—never resolves on its own, and without proper care, the consequences accumulate.[3]

Without treatment, blisters form constantly from everyday activities. These blisters, when not properly drained and cared for, can expand and merge into larger wounds. Large, open areas of damaged skin become breeding grounds for bacteria, leading to frequent and potentially severe infections. In young children, repeated infections can become life-threatening, particularly if bacteria enter the bloodstream.[11]

As wounds heal without proper wound care, they often leave behind thick, rigid scars. In severe cases, scarring around the fingers and toes can cause them to fuse together, a process that gradually limits hand and foot function. Scarring around joints can create permanent contractures that restrict movement and make it difficult or impossible to fully extend arms, legs, or fingers. Over years, these deformities worsen without intervention, leading to significant disability.[1]

When blistering affects the inside of the mouth and esophagus without treatment, eating becomes increasingly difficult and painful. The esophagus may develop strictures—areas where scarring causes the tube to narrow—making it hard to swallow even soft foods. Children fail to gain weight properly, and malnutrition becomes a serious concern. Nutritional deficiencies further impair the body’s ability to heal wounds, creating a vicious cycle of worsening health.[9]

In severe dystrophic forms of EB, the constant cycle of blistering, wounding, and scarring without proper management creates ideal conditions for cancer development. Areas of chronic wounds and repeated scarring have a much higher chance of transforming into aggressive squamous cell carcinomas. Without regular monitoring and early treatment, these cancers can spread to other parts of the body and become fatal.[6]

Possible Complications

Even with the best care, epidermolysis bullosa can lead to numerous complications that extend far beyond the visible skin problems. These complications affect nearly every body system and require vigilant monitoring and management by a team of specialists.[2]

Infections represent one of the most immediate and dangerous complications. Open wounds provide entry points for bacteria, and people with EB frequently battle skin infections. Signs of infection include increased redness and warmth around wounds (though redness may be harder to see on darker skin), pus or unusual discharge, crusting, fever, and red streaks spreading from blistered areas. When infections spread into the bloodstream, they can cause sepsis, a medical emergency that requires immediate hospitalization.[11]

Nutritional complications arise when blistering affects the mouth, throat, or esophagus. Eating becomes painful, and some individuals develop severe difficulty swallowing, a condition called dysphagia. The esophagus may narrow from scarring, requiring surgical procedures to widen it so food can pass through. Many children with severe EB struggle to consume enough calories and may need a feeding tube placed directly into the stomach to ensure adequate nutrition. Poor nutrition, in turn, slows wound healing and weakens the immune system, increasing susceptibility to infections.[9]

Anemia, or low levels of red blood cells, commonly develops in people with EB. This happens because chronic wounds lead to blood loss, the body uses iron stores trying to heal wounds, and inflammation interferes with red blood cell production. Anemia causes fatigue, weakness, and makes it harder for wounds to heal properly. Some individuals require iron supplements or even blood transfusions.[2]

Eye complications can occur when blistering affects the delicate tissues of the eyes. Blisters may form on the cornea (the clear front surface of the eye) or inside the eyelids. Repeated blistering and scarring can damage vision, cause chronic pain, and in severe cases, lead to vision loss. Some people develop sensitivity to light and need to protect their eyes carefully.[2]

Dental problems are particularly common in certain types of EB. Teeth may not develop to their expected size, decay easily, or develop structural abnormalities. The enamel coating teeth may be defective, making them prone to cavities. When blistering affects the mouth, maintaining proper oral hygiene becomes challenging yet critically important. People with EB often require specialized dental care throughout their lives.[1]

Musculoskeletal complications develop when scarring affects mobility. Fingers and toes may fuse together through a process called pseudosyndactyly, where repeated blistering and scarring causes digits to stick together. Contractures around joints limit movement and can become permanent if not addressed through physical therapy and sometimes surgery. Some people lose the ability to fully open their hands or straighten their fingers, significantly impacting independence.[2]

Cancer represents the most serious long-term complication for people with severe dystrophic EB. By their mid-twenties, individuals with recessive dystrophic EB face a dramatically elevated risk of developing aggressive squamous cell carcinomas. These cancers typically arise in areas of chronic wounds and scarring. They grow quickly, are difficult to treat, and are the leading cause of death in adults with severe EB. Regular skin examinations to detect suspicious changes early are crucial but cannot eliminate the risk.[4][6]

⚠️ Important
Breathing difficulties can emerge suddenly if blistering occurs inside the airways or if scarring causes narrowing. This is a medical emergency requiring immediate attention. Similarly, any signs of infection spreading (such as fever, widespread redness, or feeling generally unwell) should prompt urgent medical evaluation. Parents and caregivers should have a clear emergency plan discussed with their medical team.

Impact on Daily Life

Living with epidermolysis bullosa transforms everyday activities that most people take for granted into carefully planned endeavors that require patience, preparation, and often pain tolerance. The condition touches nearly every aspect of life, affecting not just the person with EB but their entire family.[21]

Personal care routines become elaborate and time-consuming. Getting dressed requires choosing clothing carefully—items must be soft, made from natural fabrics like cotton that don’t trap heat, and loose enough to avoid rubbing. Seams must be smooth or removed entirely, and tags cut out. Shoes require special attention to ensure proper fit without any pressure points that could cause blisters. Even the simple act of bathing needs careful planning, using lukewarm water (never hot), gentle cleansers, and soft materials. After bathing, patting the skin dry rather than rubbing is essential.[17]

Wound care dominates daily life for those with moderate to severe EB. Families often spend several hours each day inspecting skin, carefully draining new blisters with sterile needles, cleaning wounds, applying ointments, and wrapping affected areas with specialized non-stick bandages. This process can be painful, requiring pain medication beforehand. The supplies needed—special gauzes, ointments, bandages, and dressings—are expensive and must be constantly replenished.[11][18]

Eating presents unique challenges when blistering affects the mouth and throat. Foods must be soft or pureed, and beverages need to be lukewarm or cool—never hot. Favorite foods may become impossible to eat if they’re too hard, crunchy, or acidic. Meal times can be prolonged and uncomfortable. For children, this can lead to food aversions and anxiety around eating. Parents must become creative in preparing nutritious foods that are safe and appealing despite texture limitations.[21]

Physical activities require careful balance between staying active for health and avoiding trauma that causes blistering. Children with EB need exercise to maintain strength, flexibility, and overall health, but contact sports and rough play can cause immediate damage. Swimming is often recommended as a gentle activity, but even getting in and out of pools requires caution. Walking long distances may cause blisters on the feet, necessitating rest breaks and limiting mobility.[17]

Social and emotional impacts run deep. Children with EB may feel isolated, especially once they reach school age. They might be unable to participate in the same activities as classmates, worry about appearing different because of bandages or scars, or face questions from peers who don’t understand the condition. Friendships can be difficult to form and maintain when physical limitations prevent joining in certain activities or when frequent medical appointments interrupt school attendance.[21]

For parents and caregivers, the physical demands of caring for a child with EB are immense. The daily wound care routine is physically exhausting, and the emotional toll of knowing that routine handling causes pain creates constant stress. Sleep is often disrupted by the child’s discomfort or the need for overnight wound checks. Many parents must reduce work hours or leave jobs entirely to provide the intensive care their child needs, creating financial strain on top of the high costs of medical supplies and care.[21]

Financial burdens weigh heavily on families affected by EB. The specialized bandages, dressings, and wound care supplies are extremely expensive—some families report spending thousands of dollars monthly on supplies alone. Not all insurance companies cover these essential items adequately, forcing families to fight for coverage or pay out of pocket. Medical appointments with multiple specialists, potential hospitalizations, and lost income from reduced work hours compound the financial stress.[21]

School presents both opportunities and challenges. Education and social interaction are crucial for child development, but schools must make accommodations. Teachers and school nurses need training on how to help the child safely during the day, including wound care if blisters develop. Classmates benefit from age-appropriate education about EB to promote understanding and acceptance. Some children require modified physical education activities or need to avoid certain playground equipment. Despite challenges, maintaining school attendance and peer relationships as much as possible supports emotional health and development.[17][21]

Finding strategies to cope with limitations helps improve quality of life. Occupational therapists can teach adaptive techniques for daily activities and recommend special tools that reduce friction—such as padded grips for utensils, easy-to-fasten clothing, or doorknob extensions. Physical therapists help maintain range of motion and prevent contractures through gentle exercises and stretching. Pain management strategies, including both medication and non-drug approaches like distraction techniques during wound care, make daily routines more bearable. Connecting with other families through support groups, either in-person or online, provides emotional support and practical advice from those who truly understand the challenges.[18][21]

Support for Families Regarding Clinical Trials

Clinical trials represent hope for better treatments and potentially even cures for epidermolysis bullosa. For families dealing with this challenging condition, understanding how clinical trials work and how to access them can open doors to cutting-edge therapies not yet widely available.[5]

Clinical trials are research studies that test new treatments, medications, or medical approaches in people. For EB, trials might investigate new wound care products, pain management strategies, therapies to reduce blistering, or advanced approaches like gene therapy that aims to correct the underlying genetic defect. Some trials test medicines already approved for other conditions to see if they might help with EB symptoms—an approach called “off-label” use.[15]

Participating in a clinical trial means your family member with EB might gain access to new treatments before they become widely available. Participants typically receive close monitoring and care from specialized medical teams, often at no cost for the treatment being studied. However, trials also involve uncertainty—the experimental treatment might not work, could have unexpected side effects, or may require frequent visits to the research center, which can be burdensome for families already managing intensive daily care.[5]

Finding appropriate clinical trials requires some research. Major EB specialty centers often conduct or know about ongoing trials. Families can search the official U.S. government clinical trials database at ClinicalTrials.gov by entering “epidermolysis bullosa” to see currently enrolling studies. National EB organizations also maintain information about available trials and can help connect families with research opportunities. Each trial has specific eligibility criteria—such as age range, EB type and severity, and sometimes geographic location—so not every trial will be appropriate for every person.[5]

Relatives can play a crucial supportive role in helping a family member consider and prepare for trial participation. First, they can help gather complete medical records, including genetic testing results confirming the specific type of EB, photos documenting skin condition over time, and records of previous treatments tried. This documentation helps research teams determine eligibility and understand the person’s baseline condition.[5]

Family members can assist in evaluating whether a specific trial makes sense. Important questions to ask the research team include: What is the treatment being tested? What are the potential benefits and risks? How often will visits to the trial site be required? Will the study cover travel costs? What happens if the treatment works—can my family member continue receiving it after the trial ends? What are the alternatives if we choose not to participate? Having a support person at these discussions helps ensure all questions are asked and answers are clearly understood.[5]

Practical support is equally important. Clinical trials often require frequent visits to the study site, which may be far from home. Family members can help coordinate transportation, provide childcare for siblings during appointments, or accompany the person with EB to visits for emotional support. Keeping detailed records of symptoms, blister counts, pain levels, and any side effects during the trial helps both the family and the research team track progress.[21]

It’s essential that families understand participation is always voluntary. People can withdraw from a trial at any time without affecting their regular medical care. The decision to join should never feel rushed or pressured. Taking time to discuss as a family, consulting with your regular medical team, and potentially connecting with other families who have participated in EB research can help inform the decision.[5]

Some families find that participating in research, even if the treatment doesn’t help their own situation, gives them a sense of contributing to future advances that might help others with EB. This can be emotionally meaningful, though it should not be the sole reason for joining a trial. The primary consideration should be whether the potential benefits outweigh the risks and burdens for that individual person and family.[15]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • VYJUVEK® (beremagene geperpavec-svdt) – The first topical gene therapy approved by the FDA for treatment of wounds in patients with dystrophic epidermolysis bullosa. It works by delivering a functional copy of the COL7A1 gene to cells, allowing them to produce collagen VII protein needed for skin integrity.
  • FILSUVEZ® (birch triterpenes topical gel) – A gel containing birch bark extract approved by the FDA in 2023 for treatment of wounds in patients aged 6 months and older with junctional and dystrophic epidermolysis bullosa. It helps partial thickness wounds heal more quickly.
  • ZEVASKYN® (prademagene zamikeracel) – An autologous cell sheet-based gene therapy approved by the FDA in 2025 for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa.

Ongoing Clinical Trials on Epidermolysis bullosa

  • Study on the Effects of TCP-25 Gel for Wound Healing in Patients with Epidermolysis Bullosa

    Recruiting

    Investigated diseases:
    France Greece Italy Spain Sweden
  • Study on Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa Using Skin Grafts with Genetically Corrected Autologous Keratinocytes and Fibroblasts

    Recruiting

    1 1
    Investigated diseases:
    France
  • Study on the Effects of Deucravacitinib for Adults with Inflammatory Skin Conditions (Epidermolysis Bullosa Simplex and Congenital Ichthyoses)

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Effect of Cholestyramine on Pollutant Levels in Obese Women Eligible for Bariatric Surgery

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Austria Croatia Denmark France Germany Greece +6
  • Study on Rigosertib Sodium for Patients with Recessive Dystrophic Epidermolysis Bullosa and Advanced Squamous Cell Carcinoma

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Study on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells for Patients with Epidermolysis Bullosa

    Not recruiting

    1 1
    Investigated diseases:
    Czechia

References

https://www.mayoclinic.org/diseases-conditions/epidermolysis-bullosa/symptoms-causes/syc-20361062

https://my.clevelandclinic.org/health/diseases/17792-epidermolysis-bullosa

https://www.nhs.uk/conditions/epidermolysis-bullosa/

https://en.wikipedia.org/wiki/Epidermolysis_bullosa

https://www.debra.org/about-eb/understanding-epidermolysis-bullosa-eb

https://www.ncbi.nlm.nih.gov/books/NBK599531/

https://www.chop.edu/conditions-diseases/epidermolysis-bullosa

https://www.cincinnatichildrens.org/health/e/epidermolysis-bullosa

https://www.mayoclinic.org/diseases-conditions/epidermolysis-bullosa/diagnosis-treatment/drc-20361146

https://www.aad.org/public/diseases/a-z/epidermolysis-bullosa-treatment

https://www.nhs.uk/conditions/epidermolysis-bullosa/treatment/

https://www.cincinnatichildrens.org/health/e/epidermolysis-bullosa

https://www.debra.org/about-eb/approved-treatments-eb

https://www.childrenscolorado.org/advances-answers/recent-articles/epidermolysis-bullosa-treatment/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6900197/

https://emedicine.medscape.com/article/1062939-treatment

https://www.aad.org/public/diseases/a-z/epidermolysis-bullosa-self-care

https://www.debra.org/more-eb-guides/daily-living

https://pmc.ncbi.nlm.nih.gov/articles/PMC10921121/

https://my.clevelandclinic.org/health/diseases/17792-epidermolysis-bullosa

https://epidermolysisbullosanews.com/living-epidermolysis-bullosa/

https://www.mayoclinic.org/diseases-conditions/epidermolysis-bullosa/diagnosis-treatment/drc-20361146

https://www.cincinnatichildrens.org/health/e/epidermolysis-bullosa

https://www.almondcare.co.uk/a-guide-to-caring-for-those-with-epidermolysis-bullosa/

https://www.news-medical.net/health/Treatment-and-Tips-for-Epidermolysis-Bullosa.aspx

FAQ

Is epidermolysis bullosa contagious?

No, epidermolysis bullosa is not contagious at all. It is a genetic disorder caused by inherited mutations in genes, meaning it is passed down through families or occurs as a spontaneous genetic change. You cannot catch EB from someone else through contact, sharing items, or any other means.

Can epidermolysis bullosa be cured?

Currently, there is no cure for epidermolysis bullosa. Treatment focuses on caring for blisters and wounds, preventing new blisters from forming, controlling infections, managing pain, and treating complications as they arise. However, recent advances in gene therapy and new topical treatments offer hope for improved management, and research continues toward finding a cure.

How is epidermolysis bullosa diagnosed?

EB is usually diagnosed based on the appearance of the skin, often at birth or in early childhood. To confirm the diagnosis and determine the specific type, doctors may perform a skin biopsy using a special microscopy technique called immunofluorescence mapping, or genetic testing using a blood or saliva sample. Genetic testing is now the preferred diagnostic method.

Will my child with mild EB outgrow the condition?

Some mild forms of EB, particularly certain types of EB simplex, may improve with age. However, EB is a lifelong genetic condition that does not completely go away. As children grow, they often learn better ways to protect their skin and avoid activities that cause blistering, which can make the condition easier to manage over time.

What type of doctor treats epidermolysis bullosa?

A dermatologist (skin specialist) typically leads the care team for someone with EB. However, because EB affects multiple body systems, care usually involves a multidisciplinary team that may include wound care nurses, nutritionists, dentists, gastroenterologists, ophthalmologists, physical therapists, pain specialists, and social workers. Specialized EB centers have experience with these complex care needs.

🎯 Key takeaways

  • Epidermolysis bullosa is not one disease but a group of over 30 different genetic subtypes, each with dramatically different severity and prognosis.
  • Daily wound care for severe EB can take several hours and require expensive specialized supplies that cost families thousands of dollars monthly.
  • The most serious long-term risk for people with severe dystrophic EB is aggressive squamous cell carcinoma, which is the leading cause of death in this population.
  • Three medications have been approved by the FDA specifically for treating EB wounds, including two gene therapy approaches, marking significant progress in treatment options.
  • Even mild activities like wearing shoes, eating crunchy foods, or playing can cause blistering, requiring constant vigilance and lifestyle modifications.
  • An estimated 1 in 50,000 people in the United States has EB, making it rare enough that many medical professionals have limited experience with the condition.
  • Infections in open wounds represent one of the most immediate dangers for people with EB and require prompt medical attention when signs appear.
  • Support networks—including specialized EB centers, national organizations, and connections with other affected families—are vital for helping families navigate the physical, emotional, and financial challenges of living with EB.